Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn
2011

How Lck and Fyn Kinases Affect Tau Phosphorylation in Alzheimer's Disease

publication 10 minutes Evidence: moderate

Author Information

Author(s): Timothy ME Scales, Pascal Derkinderen, Kit-Yi Leung, Helen L Byers, Malcolm A Ward, Caroline Price, Ian N Bird, Timothy Perera, Stuart Kellie, Ritchie Williamson, Brian H Anderton, C Hugh Reynolds

Primary Institution: MRC Centre for Neurodegeneration Research, King's College London

Hypothesis

Lck and Fyn kinases have different effects on the phosphorylation of tau protein, which may influence Alzheimer's disease pathology.

Conclusion

Lck and Fyn have subtle differences in their properties as tau kinases, suggesting that Lck may play a unique role in Alzheimer's disease pathology.

Supporting Evidence

  • Lck and Fyn both phosphorylate tau, but Lck shows a preference for phosphorylating tyrosines other than Tyr18.
  • Mutating tyrosines in tau reduces its phosphorylation by Lck, indicating multiple phosphorylation sites.
  • Phosphorylation of tau by Lck may contribute to the pathology of Alzheimer's disease.

Takeaway

This study looks at two proteins, Lck and Fyn, that can add special tags to another protein called tau. These tags might help us understand how tau behaves in diseases like Alzheimer's.

Methodology

The study used in vitro phosphorylation assays and co-transfection experiments in COS-7 cells to analyze tau phosphorylation by Lck and Fyn.

Limitations

The study primarily focuses on in vitro and co-transfection models, which may not fully represent in vivo conditions.

Digital Object Identifier (DOI)

10.1186/1750-1326-6-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication